Monotherapy Epilepsy: Topiramate (Trokendi XR) is indicated as initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 6 years of age and older (see Pharmacology: Pharmacodynamics: Clinical Studies: Monotherapy Epilepsy under Actions).
Adjunctive Therapy Epilepsy: Topiramate (Trokendi XR) is indicated as adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome in patients 6 years of age and older (see Pharmacology: Pharmacodynamics: Clinical Studies: Adjunctive Therapy Epilepsy under Actions).
Migraine: Topiramate (Trokendi XR) is indicated for the prophylaxis of migraine headache in patients 12 years of age and older (see Pharmacology: Pharmacodynamics: Clinical Studies: Migraine Prophylaxis under Actions).
Other Services
Country
Account